FI51098B - - Google Patents

Info

Publication number
FI51098B
FI51098B FI750944A FI750944A FI51098B FI 51098 B FI51098 B FI 51098B FI 750944 A FI750944 A FI 750944A FI 750944 A FI750944 A FI 750944A FI 51098 B FI51098 B FI 51098B
Authority
FI
Finland
Application number
FI750944A
Other languages
Finnish (fi)
Other versions
FI51098C (fi
Inventor
Ulf Wennstroem
Original Assignee
Medipolar Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medipolar Oy filed Critical Medipolar Oy
Priority to FI750944A priority Critical patent/FI51098C/fi
Priority to JP1838876A priority patent/JPS51113867A/ja
Priority to YU45476A priority patent/YU45476A/xx
Priority to ES445762A priority patent/ES445762A1/es
Priority to NL7602263A priority patent/NL7602263A/xx
Priority to CA247,190A priority patent/CA1059137A/en
Priority to PT6493376A priority patent/PT64933B/pt
Priority to CH361876A priority patent/CH599151A5/de
Priority to AT223576A priority patent/AT347447B/de
Application granted granted Critical
Publication of FI51098B publication Critical patent/FI51098B/fi
Publication of FI51098C publication Critical patent/FI51098C/fi
Priority to SU772549949A priority patent/SU655304A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI750944A 1975-03-27 1975-03-27 Menetelmä terapeuttisesti arvokkaan 2-okso-1-pyrrolidinyyliasetamidin valmistamiseksi. FI51098C (fi)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FI750944A FI51098C (fi) 1975-03-27 1975-03-27 Menetelmä terapeuttisesti arvokkaan 2-okso-1-pyrrolidinyyliasetamidin valmistamiseksi.
JP1838876A JPS51113867A (en) 1975-03-27 1976-02-21 Production of pharmaceutically useful 22oxoo11pyrodinyl acetamide
YU45476A YU45476A (en) 1975-03-27 1976-02-24 Process for obtaining 2-oxo-pyrrolidinyl ecetamide
NL7602263A NL7602263A (nl) 1975-03-27 1976-03-04 Werkwijze voor de bereiding van het terapeutisch waardevolle 2-oxo-1-pyrrolidinylacetamide.
ES445762A ES445762A1 (es) 1975-03-27 1976-03-04 Procedimiento para preparar 2-oxo-1-pirrolidinilacetamida.
CA247,190A CA1059137A (en) 1975-03-27 1976-03-05 Process for the preparation of therapeutically valuable 2-oxo-1-pyrrolidinylacetamide
PT6493376A PT64933B (en) 1975-03-27 1976-03-22 Process for the preparation of therapeutically valuable 2-oxo-1-pyrrolidinylacetamide
CH361876A CH599151A5 (en) 1975-03-27 1976-03-23 Cerebrotonic 2-oxo-pyrrolidine-1-acetamide prepn.
AT223576A AT347447B (de) 1975-03-27 1976-03-26 Verfahren zur herstellung des 2-oxo-1- pyrrolidinylacetamids
SU772549949A SU655304A3 (ru) 1975-03-27 1977-12-05 Способ получени этилового эфира -карбамоилметил-4-аминомасл ной кислоты

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI750944A FI51098C (fi) 1975-03-27 1975-03-27 Menetelmä terapeuttisesti arvokkaan 2-okso-1-pyrrolidinyyliasetamidin valmistamiseksi.

Publications (2)

Publication Number Publication Date
FI51098B true FI51098B (xx) 1976-06-30
FI51098C FI51098C (fi) 1976-10-11

Family

ID=8509097

Family Applications (1)

Application Number Title Priority Date Filing Date
FI750944A FI51098C (fi) 1975-03-27 1975-03-27 Menetelmä terapeuttisesti arvokkaan 2-okso-1-pyrrolidinyyliasetamidin valmistamiseksi.

Country Status (10)

Country Link
JP (1) JPS51113867A (xx)
AT (1) AT347447B (xx)
CA (1) CA1059137A (xx)
CH (1) CH599151A5 (xx)
ES (1) ES445762A1 (xx)
FI (1) FI51098C (xx)
NL (1) NL7602263A (xx)
PT (1) PT64933B (xx)
SU (1) SU655304A3 (xx)
YU (1) YU45476A (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT391134B (de) * 1979-03-22 1990-08-27 Continental Pharma Verfahren zum herstellen von neuen glycinamidderivaten, deren additionssalzen und deren optischen isomeren
IT1206699B (it) * 1984-02-27 1989-04-27 Isf Spa Procedimento per preparare derivati di pirrolidone.
EP0223328B1 (en) 1985-07-26 1992-01-29 Denki Kagaku Kogyo Kabushiki Kaisha Process for producing oxiracetam
CH680293A5 (xx) * 1990-06-26 1992-07-31 Lonza Ag
JP2969616B2 (ja) * 1994-11-24 1999-11-02 田辺製薬株式会社 ４−メルカプトピロリジン化合物の製法
PL389364A1 (pl) 2009-10-23 2011-04-26 Uniwersytet Jagielloński Nowe zastosowanie pochodnych 2-pirolidonu
RU2629117C1 (ru) * 2016-06-14 2017-08-24 Сизов Владимир Владимирович Способ получения 4-замещенного 2-[2-оксо-1-пирролидинил] ацетамида

Also Published As

Publication number Publication date
ES445762A1 (es) 1977-06-01
PT64933B (en) 1977-08-24
JPS51113867A (en) 1976-10-07
PT64933A (en) 1976-04-01
JPS5652017B2 (xx) 1981-12-09
AT347447B (de) 1978-12-27
FI51098C (fi) 1976-10-11
CH599151A5 (en) 1978-05-12
SU655304A3 (ru) 1979-03-30
YU45476A (en) 1982-05-31
ATA223576A (de) 1978-05-15
NL7602263A (nl) 1976-09-29
CA1059137A (en) 1979-07-24

Similar Documents

Publication Publication Date Title
CH596345A5 (xx)
AU495836B2 (xx)
CH600537A5 (xx)
BG22748A1 (xx)
BG21624A1 (xx)
BG22104A1 (xx)
BG22115A1 (xx)
BG22120A1 (xx)
BG22152A1 (xx)
BG22273A1 (xx)
BG22431A1 (xx)
BG22483A1 (xx)
BG22542A1 (xx)
CH600974A5 (xx)
BG22763A1 (xx)
BG22878A1 (xx)
CH1355175A4 (xx)
CH584348A5 (xx)
CH585086A5 (xx)
CH586393A5 (xx)
CH586397A5 (xx)
CH587511B5 (xx)
CH589394A5 (xx)
CH590481A5 (xx)
CH590551A5 (xx)

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: MEDIPOLAR OY